CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.9489
+0.1039 (12.30%)
Aug 14, 2026, 4:00 PM EDT - Market closed
CytoMed Therapeutics Cash Flow Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -3.98 | -2.52 | -4.13 | -3.13 | -2.05 |
Depreciation & Amortization | 0.4 | 0.33 | 0.38 | 0.39 | 0.33 |
Other Amortization | 0 | 0 | - | - | 0 |
Loss (Gain) From Sale of Assets | - | - | - | -0 | - |
Asset Writedown & Restructuring Costs | 0.01 | - | - | 0 | - |
Loss (Gain) From Sale of Investments | -0.29 | - | - | - | - |
Loss (Gain) on Equity Investments | 0.01 | -0.01 | 0.03 | 0.03 | 0.21 |
Stock-Based Compensation | 0.69 | - | - | - | - |
Other Operating Activities | -0.05 | -0.45 | 0.08 | 1.2 | 0.17 |
Change in Accounts Receivable | -0.56 | -0.08 | -0.01 | -0.15 | -0.43 |
Change in Accounts Payable | -0 | -0.08 | 0.11 | 0.27 | 0.06 |
Change in Unearned Revenue | 0.07 | 0.1 | 0 | -0.01 | - |
Operating Cash Flow | -3.7 | -2.71 | -3.53 | -1.4 | -1.71 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.64 | -1.4 | -0.06 | -0.47 | -0.58 |
Sale of Property, Plant & Equipment | - | - | - | 0 | - |
Divestitures | 0.7 | 0.16 | - | - | - |
Sale (Purchase) of Intangibles | -0.07 | -0.09 | - | - | - |
Investment in Securities | 0.77 | 2.5 | -2.77 | - | -0.24 |
Other Investing Activities | 0.13 | 0.47 | 0.1 | - | - |
Investing Cash Flow | 0.93 | 1.13 | -2.73 | -0.47 | -0.82 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | 0.3 | 0.35 |
Total Debt Issued | - | - | - | 0.3 | 0.35 |
Short-Term Debt Repaid | - | - | -0.3 | -0.35 | - |
Long-Term Debt Repaid | -0.05 | -0.04 | -0.04 | -0.08 | -0.06 |
Total Debt Repaid | -0.05 | -0.04 | -0.34 | -0.43 | -0.06 |
Net Debt Issued (Repaid) | -0.05 | -0.04 | -0.34 | -0.13 | 0.29 |
Issuance of Common Stock | 0.28 | - | 11.31 | 1.22 | 4 |
Other Financing Activities | -0.02 | -0.02 | -0.05 | -0.13 | -0.12 |
Financing Cash Flow | 0.21 | -0.06 | 10.92 | 0.97 | 4.17 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.04 | 0.12 | -0.01 | -0.03 | -0.01 |
Net Cash Flow | -2.6 | -1.53 | 4.64 | -0.93 | 1.63 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4.34 | -4.11 | -3.59 | -1.87 | -2.3 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -503.61% | -816.52% | -706.96% | -514.47% | -2016.27% |
Free Cash Flow Per Share | -0.37 | -0.36 | -0.34 | -0.24 | -0.33 |
Levered Free Cash Flow | -2.72 | -3.17 | -2.04 | -1.29 | -1.75 |
Unlevered Free Cash Flow | -2.7 | -3.16 | -2.01 | -1.21 | -1.68 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.02 | 0.02 | 0.05 | 0.13 | 0.12 |
Cash Income Tax Paid | - | - | 0 | - | - |
Change in Working Capital | -0.49 | -0.06 | 0.1 | 0.11 | -0.37 |